- Home
- FGI vs AYTU Comparison
FGI vs AYTU Comparison
Compare FGI & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- AYTU
- Stock Information
- Founded
- FGI 1987
- AYTU N/A
- Country
- FGI United States
- AYTU United States
- Employees
- FGI N/A
- AYTU N/A
- Industry
- FGI Industrial Specialties
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- AYTU Health Care
- Exchange
- FGI Nasdaq
- AYTU Nasdaq
- Market Cap
- FGI 9.4M
- AYTU 9.8M
- IPO Year
- FGI 2022
- AYTU N/A
- Fundamental
- Price
- FGI $0.80
- AYTU $1.35
- Analyst Decision
- FGI
- AYTU
- Analyst Count
- FGI 0
- AYTU 0
- Target Price
- FGI N/A
- AYTU N/A
- AVG Volume (30 Days)
- FGI 10.0K
- AYTU 37.2K
- Earning Date
- FGI 11-11-2024
- AYTU 02-12-2025
- Dividend Yield
- FGI N/A
- AYTU N/A
- EPS Growth
- FGI N/A
- AYTU N/A
- EPS
- FGI N/A
- AYTU N/A
- Revenue
- FGI $127,180,460.00
- AYTU $79,759,000.00
- Revenue This Year
- FGI $11.39
- AYTU N/A
- Revenue Next Year
- FGI $6.26
- AYTU N/A
- P/E Ratio
- FGI N/A
- AYTU N/A
- Revenue Growth
- FGI 7.71
- AYTU N/A
- 52 Week Low
- FGI $0.70
- AYTU $1.30
- 52 Week High
- FGI $1.85
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- FGI 45.90
- AYTU 36.89
- Support Level
- FGI $0.75
- AYTU $1.30
- Resistance Level
- FGI $0.89
- AYTU $1.44
- Average True Range (ATR)
- FGI 0.05
- AYTU 0.11
- MACD
- FGI 0.00
- AYTU -0.00
- Stochastic Oscillator
- FGI 35.71
- AYTU 24.42
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.